Determination of the ratio of testosterone to epitestosterone (TIE) in urine is used to detect testosterone administration in athletes, with a ratio >6 considered as evidence of an offense. We show that administrationof ketoconazole, which inhibitstestosterone biosynthesis,may be useful for differentiating between an athlete who is using testosterone and one who naturally gives a ratio >6. In a control subject pretreated with testosterone, ketoconazole caused the ratio to increase; conversely, it caused a decrease in the ratio in an athlete under investigation. Repeated administration of ketoconazole to two normal men caused a decrease in the ratio due to a large decrease in the urinary excretion rate of testosterone relative to epitestosterone. Stimulation with human chorionic gonadotropin exacerbated the differences in excretion rates. A single administration of ketoconazole to six normal men caused the TIE ratios to decrease signifi- 
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oratories.5
The IOC states that the banned class of anabolic steroids includes substances that are related in structure and activity to testosterone. Currently, only untimed urine samples are collected from athletes to determine whether a banned drug has been administered. For detection of foreign steroids, all that is required is unequivocal identification in the urine sample of the parent compound or a diagnostic metabolite. Results of analysis from all of the IOC-accredited laboratories in 1991 suggest that the majority of athletes who misuse steroids appear now to have switched to the naturally occurring androgen testosterone to evade detection. ' To investigate further the effect of ketoconazole on the TIE ratio, we administered ketoconazole twice daily to two normal male volunteers, to maintain the 17a-hydroxylase-17,20-lyase block. During the period of ketoconazole administration, hCG was also given to exacerbate any resulting difference between the urinary excretion rates of epitestosterone and testosterone. These two volunteers had previously been shown to respond to hCG stimulation with a large but comparable increase in their urinary excretion rates of both testosterone and epitestosterone, with hence little change in their urinary TIE ratios (3).
Finally, we undertook a third experiment, to examine whether ketoconazole would also cause a significant decrease in the TIE ratios of six normal men between 6 and 8 h after administration; such a time scale would be suitable for the introduction of a dynamic test.
MaterIals and Methods
The procedures followed were in accordance with the ethical standards of our institutions, and informed consent was obtained from all the subjects who volunteered for this study.
Experiment 1

Effect of repeated ketoconazole administration on an athlete with an above-normal
TIE ratio, on a control, and on the same control after testosterone administration. A urine sample collected from a Norwegian male athlete (23 years old) of Olympic standard was analyzed by the
IOC-accredited laboratory
at The Aker Hospital, Oslo, Norway. Extraction and gas chromatography-mass spectrometry analysis (GC-MS) of anabolic steroids by a validated method (15) showed that the abundance of the bis-trimethylsilyl ether (TMS) derivatives of the molecular ions of testosterone and epitestosterone gave a TIE ratio of 9.4. The athlete, in pleading his innocence, presented himself for clinical investigation to The Aker Hospital. The athlete consented that during the clinical investigation he would be taken at any time without forewarning to another clinical establishment and once there he would be quarantined for up to 2 weeks. Quarantining of the athlete, which was at Sunnaas Hospital in Norway, was deemed necessary to ensure that tests could take place under controlled conditions. Before departure, the athlete was body-searched and all his belongings were inspected by a qualified sampling officer. The athlete was not informed where he was to be quarantined and had no access to send messages for outside communication during the quarantine period. Importantly, he was in the constant presence of at least one sampling officer throughout that period. All food brought in was ordered and checked by the sampling officers, who also ensured that all the athlete's urine was properly collected as described in the IOC standard operating procedures.
During the quarantine period (days -2 to 5 of the study) ketoconazole (Nizoral#{174}; 400 mg orally) was administered at midnight on days 0, 1, and 2. Throughout the period, the athlete was instructed to void his bladder at 0600; subsequent urine together with a venous blood sample was collected for analysis at 0800. The results were compared with those for a normal adult male volunteer (39 years old) who was given the same regime of ketoconazole administration.
Nine months later, the treatment regime was repeated on the same volunteer, 7 days after administration of testosterone heptanoate (Primoteston depot#{174}; 250 mg intramuscularly). 
Experiment2
Effect of repeated ketoconazole with hCG administration on the urinary excretion rates of testosterone and epitestosterone in two normal men. Ketoconazole (300 mg) was administered orally at 1000 and 2200, on days 0 to 6, to two healthy male volunteers, ages 28 (subject 1) and 33 years (subject 2). At 1200 noon on day 2 a single intramuscular dose of hCG (5000 IU; Profasi#{174}) was given.
All urine samples were collected from each subject from 1000 to 2200 and from 2200 to 1000 on days -2 to 10 (i.e., two pooled samples apiece each day) and the pooled urine volumes recorded. All the urine samples were divided into polypropylene containers, frozen rapidly in liquid nitrogen, and stored at -70 #{176}C before analysis.
The hydrolysis and extraction of the steroid glucuronide conjugates was by a method previously described The abundance ratios were then calculated for each sample and the steroid concentrations were interpolated from the respective curves.
Between-assay CVs for quality-control samples (n = 24) for the analysis of urinary total testosterone were 4.8% ( = 69 nmol/L) and 10.6% (x = 159 nmoIJL) and for total epitestosterone were 9.8% (x = 10.5 nmol/L) and 13.2% (x = 216 nmoIJL).
Experiment 3
Effect of ketoconazole administration on the urinary TIE ratios in six normal men. Six healthy male volunteers (ages 22-40 years, mean 29 years) received ketoconazole (400 mg) orally at 1000. Urine samples were collected just before the dose (basal, t =0 h) and between 0 and 4,4 and 6, and 6 and 8 h after the dose; these were designated as time 0 h, 2 h, 5 h, and 7 h, respectively. The total concentrations of testosterone and epitestosterone in the urine were measured by GC-MS by a method previously described (3). (Figure 1 ). In contrast, only minor changes were observed in the same control after previous administration of testosterone heptanoate on day -7. The changes in urinary TIE ratios after ketoconazole administration are given in Figure 2 . There were pronounced decreases in the ratios for the athlete and control during ketoconazole administration. Conversely, after testosterone administration, the augmented TIE ratio achieved in the control was further increased after ketoconazole administration. The urinary TIE ratios followed a similar pattern in both subjects (Figure 3) , decreasing within the first 12 h of ketoconazole administration, remaining suppressed despite hCG stimulation, and rising above basal values upon discontinuation of ketoconazole. Compared with testosterone, the relative decrease in the urinary excretion rates of epitestosterone was much less for both subjects 2 days after ketoconazole administration (Figure 4 ). After hCG stimulation on day 2, the excretion rate of epitestosterone increased above basal values for subject 1 and returned to basal values for subject 2, whereas the excretion rate of testosterone remained below basal values for both subjects throughout the administration period. 
Results
Experiment
Discussion
The decrease in the serum concentrations of testosterone in the athlete and the control subject in response to ketoconazole was typical of that observed in other studies (8-10). Comparison with the control's response after testosterone heptanoate administration indicated that this athlete had a naturally large urinary TIE ratio and that he was not taking exogenous testosterone. further functional tests with dexamethasone and gonadotropin-releasing hormone supported this finding (14), and similar cases of biological outliers have recently been reported in one adult and two adolescents (18) . The decrease in the T/E ratio for the athlete after ketoconazole was unexpected, because the relative change in the rate of excretion of epitestosterone usually matches that of testosterone in normal men, even after hCG stimulation (2, 3) .
Indeed,
The second experiment, albeit involving only two subjects, showed that the decrease in the TIE ratios after Of course, the ethics of giving a drug to an otherwise healthy individual should be given due consideration before a dynamic test is instituted.
In conclusion, our results demonstrate that ketoconazole causes differential suppression in the urinary excretion rates of testosterone and epitestosterone. The administration of ketoconazole to an athletewith a naturally above-normal TIE ratio results in a decrease in the ratio but causes the ratio to increase in normal men who have received exogenous testosterone.
This difference in responses indicates that ketoconazole could be used to distinguish between male athletes with naturally large TIE ratios and those who have large ratios due to testosterone administration.
The substantial decrease in the urinary TIE ratios in normal men 6-8 h after a single administration of ketoconazole (400 mg, orally) means that the time scale involved would allow the ketoconazole test to be carried out within a designated room in the presence of a sampling officer without too much inconvenience.
Moreover, the fact that only urine samples would be required adds to the simplicity of the test as well as the analysis. Investigations are currently underway to develop the ketoconazole test.
